Literature DB >> 28650935

Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease.

Erick F Mayer1, Philip Gialanella, Iona Munjal, Charlotte Cunningham-Rundles, Jasmeen Dara.   

Abstract

Granulibacter bethesdensis is a Gram-negative bacillus described as a pathogen exclusively in patients with chronic granulomatous disease, a phagocytic disorder that impairs the ability to clear catalase-producing organisms. Granulibacter usually causes chronic and recurrent lymphadenopathies. We report the fatal case of a 4-year-old boy with chronic granulomatous disease, who presented with sepsis after a few days of abdominal pain and diarrhea.

Entities:  

Mesh：

Year:  2017        PMID： 28650935      PMCID： PMC5897898          DOI： 10.1097/INF.0000000000001659

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  7 in total

1.  Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.

Authors:  Kol A Zarember; Kimberly R Marshall-Batty; Anna R Cruz; Jessica Chu; Michael E Fenster; Adam R Shoffner; Larissa S Rogge; Adeline R Whitney; Meggan Czapiga; Helen H Song; Pamela A Shaw; Kunio Nagashima; Harry L Malech; Frank R DeLeo; Steven M Holland; John I Gallin; David E Greenberg
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

2.  Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.

Authors:  Jessica Chu; Margery G Smelkinson; David W Dorward; Kol A Zarember; John I Gallin
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  Serologic reactivity to the emerging pathogen Granulibacter bethesdensis.

Authors:  David E Greenberg; Adam R Shoffner; Kimberly R Marshall-Batty; Kriti Arora; Ming Zhao; Raynaldo Martin; Li Ding; Carl H Hammer; Pamela A Shaw; Douglas B Kuhns; Harry L Malech; John I Gallin; Kol A Zarember; Steven M Holland
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

4.  Granulibacter bethesdensis isolated in a child patient with chronic granulomatous disease.

Authors:  F C Rodríguez López; F Franco-Alvarez de Luna; M C Gamero Delgado; I Ibarra de la Rosa; S Valdezate; J A Saez Nieto; M Casal
Journal:  J Infect       Date:  2008-06-16       Impact factor: 6.072

5.  Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.

Authors:  David E Greenberg; Adam R Shoffner; Adrian M Zelazny; Michael E Fenster; Kol A Zarember; Frida Stock; Li Ding; Kimberly R Marshall-Batty; Richard L Wasserman; David F Welch; Kishore Kanakabandi; Dan E Sturdevant; Kimmo Virtaneva; Stephen F Porcella; Patrick R Murray; Harry L Malech; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

6.  A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.

Authors:  David E Greenberg; Li Ding; Adrian M Zelazny; Frida Stock; Alexandra Wong; Victoria L Anderson; Georgina Miller; David E Kleiner; Allan R Tenorio; Lauren Brinster; David W Dorward; Patrick R Murray; Steven M Holland
Journal:  PLoS Pathog       Date:  2006-04-14       Impact factor: 6.823

7.  Methylotroph Infections and Chronic Granulomatous Disease.

Authors:  E Liana Falcone; Jennifer R Petts; Mary Beth Fasano; Bradley Ford; William M Nauseef; João Farela Neves; Maria João Simões; Millard L Tierce; M Teresa de la Morena; David E Greenberg; Christa S Zerbe; Adrian M Zelazny; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883
  7 in total
  2 in total

1.  Fatal Meningitis in Patient with X-Linked Chronic Granulomatous Disease Caused by Virulent Granulibacter bethesdensis.

Authors:  Mafalda Rebelo; Li Ding; Ana Isabel Cordeiro; Conceição Neves; Maria João Simões; Adrian M Zelazny; Steven M Holland; João Farela Neves
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

2.  Granulibacter bethesdensis, a Pathogen from Patients with Chronic Granulomatous Disease, Produces a Penta-Acylated Hypostimulatory Glycero-D-talo-oct-2-ulosonic Acid-Lipid A Glycolipid (Ko-Lipid A).

Authors:  Artur Muszyński; Kol A Zarember; Christian Heiss; Joseph Shiloach; Lars J Berg; John Audley; Arina Kozyr; David E Greenberg; Steven M Holland; Harry L Malech; Parastoo Azadi; Russell W Carlson; John I Gallin
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.